| Primary |
| Hypercholesterolaemia |
18.8% |
| Hypertension |
17.4% |
| Blood Cholesterol Increased |
13.2% |
| Diabetes Mellitus |
7.6% |
| Hyperlipidaemia |
7.1% |
| Product Used For Unknown Indication |
6.6% |
| Ill-defined Disorder |
3.5% |
| Dyslipidaemia |
3.3% |
| Coronary Artery Disease |
2.6% |
| Prophylaxis |
2.5% |
| Blood Cholesterol Abnormal |
2.2% |
| Myocardial Infarction |
2.2% |
| Type 2 Diabetes Mellitus |
2.1% |
| Blood Cholesterol |
1.9% |
| Myocardial Ischaemia |
1.9% |
| Angina Pectoris |
1.4% |
| Depression |
1.4% |
| Pain |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
| Atrial Fibrillation |
1.3% |
|
| Myalgia |
15.3% |
| Rhabdomyolysis |
15.1% |
| Drug Ineffective |
8.6% |
| Pain In Extremity |
7.9% |
| Muscle Spasms |
7.3% |
| Nausea |
4.5% |
| Drug Interaction |
4.2% |
| Pain |
4.2% |
| Rash |
4.2% |
| Malaise |
3.6% |
| Myocardial Infarction |
3.2% |
| Pruritus |
3.2% |
| Diarrhoea |
2.8% |
| Blood Cholesterol Increased |
2.6% |
| Weight Decreased |
2.5% |
| Diabetes Mellitus |
2.4% |
| Oedema Peripheral |
2.4% |
| Dizziness |
2.1% |
| Arthralgia |
2.0% |
| Cerebral Infarction |
2.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
19.0% |
| Product Used For Unknown Indication |
15.1% |
| Blood Cholesterol Increased |
14.9% |
| Hypertension |
10.9% |
| Hypercholesterolaemia |
7.0% |
| Hyperlipidaemia |
4.8% |
| Diabetes Mellitus |
4.4% |
| Rheumatoid Arthritis |
2.5% |
| Type 2 Diabetes Mellitus |
2.4% |
| Type Iia Hyperlipidaemia |
2.4% |
| Cardiac Disorder |
2.3% |
| Depression |
2.2% |
| Coronary Artery Disease |
2.0% |
| Dyslipidaemia |
1.7% |
| Atrial Fibrillation |
1.6% |
| Ischaemic Cardiomyopathy |
1.5% |
| Myocardial Infarction |
1.4% |
| Prophylaxis |
1.4% |
| Asthma |
1.3% |
| Blood Cholesterol Abnormal |
1.3% |
|
| Rhabdomyolysis |
15.9% |
| Myalgia |
14.4% |
| Weight Decreased |
6.2% |
| Completed Suicide |
4.5% |
| Muscle Spasms |
4.5% |
| Renal Failure |
4.5% |
| Vitreous Detachment |
4.3% |
| Vomiting |
4.3% |
| Pain In Extremity |
4.1% |
| Renal Failure Acute |
4.1% |
| Rash |
3.9% |
| Drug Ineffective |
3.8% |
| Arthralgia |
3.2% |
| Diarrhoea |
3.2% |
| Hallucination |
3.2% |
| Mesothelioma |
3.2% |
| Myocardial Infarction |
3.2% |
| Pruritus |
3.2% |
| Weight Increased |
3.2% |
| Pain |
3.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
33.1% |
| Product Used For Unknown Indication |
18.3% |
| Hypertension |
10.8% |
| Rheumatoid Arthritis |
6.4% |
| Diabetes Mellitus |
3.6% |
| Prophylaxis |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Blood Cholesterol Increased |
2.6% |
| Hypercholesterolaemia |
2.2% |
| Insomnia |
2.1% |
| Hiv Infection |
2.1% |
| Pain |
2.0% |
| Depression |
1.8% |
| Hyperlipidaemia |
1.7% |
| Atrial Fibrillation |
1.6% |
| Osteoporosis |
1.4% |
| Coronary Artery Disease |
1.3% |
| Blood Cholesterol |
1.3% |
| Acute Myocardial Infarction |
1.1% |
| Angina Pectoris |
1.0% |
|
| Vomiting |
12.9% |
| Renal Failure Acute |
8.1% |
| Myocardial Infarction |
6.5% |
| Weight Decreased |
6.3% |
| Insomnia |
5.6% |
| Thrombocytopenia |
5.3% |
| Pyrexia |
4.9% |
| Urinary Tract Infection |
4.8% |
| Renal Failure |
4.7% |
| Pruritus |
4.3% |
| Weight Increased |
4.2% |
| Death |
3.8% |
| Pneumonia |
3.8% |
| Syncope |
3.8% |
| Nausea |
3.8% |
| Tremor |
3.5% |
| Somnolence |
3.5% |
| Dysgeusia |
3.4% |
| Middle Insomnia |
3.4% |
| Sepsis |
3.2% |
|
| Interacting |
| Drug Use For Unknown Indication |
29.2% |
| Product Used For Unknown Indication |
17.4% |
| Hypercholesterolaemia |
6.6% |
| Atrial Fibrillation |
5.9% |
| Hyperlipidaemia |
4.6% |
| Depression |
4.3% |
| Hypertension |
3.4% |
| Diabetes Mellitus |
3.2% |
| Parkinson's Disease |
3.2% |
| Ventricular Tachycardia |
3.2% |
| Antiplatelet Therapy |
2.5% |
| Osteomyelitis |
2.5% |
| Leukocytosis |
2.3% |
| Pain |
2.3% |
| Gastric Ulcer |
2.1% |
| Ill-defined Disorder |
1.8% |
| Acute Coronary Syndrome |
1.4% |
| Angina Pectoris |
1.4% |
| Anticoagulant Therapy |
1.4% |
| Blood Cholesterol Increased |
1.4% |
|
| Drug Interaction |
27.8% |
| Rhabdomyolysis |
17.8% |
| Ventricular Dysfunction |
7.8% |
| Aspartate Aminotransferase Increased |
4.4% |
| Renal Failure Acute |
4.4% |
| Electrocardiogram Qt Prolonged |
3.3% |
| International Normalised Ratio Increased |
3.3% |
| Myalgia |
3.3% |
| Myocardial Infarction |
3.3% |
| Paralysis |
3.3% |
| Septic Shock |
3.3% |
| Alanine Aminotransferase Increased |
2.2% |
| Convulsion |
2.2% |
| High Density Lipoprotein Decreased |
2.2% |
| Low Density Lipoprotein Increased |
2.2% |
| Musculoskeletal Stiffness |
2.2% |
| Suicidal Behaviour |
2.2% |
| Ventricular Arrhythmia |
2.2% |
| Blood Creatine Phosphokinase Increased |
1.1% |
| Cerebral Haematoma |
1.1% |
|
